Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 37: 742-747, 1991;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brustolin, D.
Right arrow Articles by Berti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brustolin, D.
Right arrow Articles by Berti, G.

Clinical Chemistry, Vol 37, 742-747, Copyright © 1991 by American Association for Clinical Chemistry

Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B

D Brustolin, M Maierna, F Aguzzi, F Zoppi, G Tarenghi and G Berti
Research & Development Laboratory and Scientific Department, Bayer Diagnostici SpA, Milan, Italy.

A simple immunoturbidimetric method for quantifying apolipoproteins (apo) A-I and B in serum or plasma is described. A special reagent formulation, including large amounts of suitable detergents, obviates the need for a sample blank even with grossly lipemic specimens. The assay is rapid, easily automated, and thus convenient for routine work. For both apo A-I and apo B, the assay range is about 0.2-3.5 g/L. The performance characteristics were assessed with discrete (Optimate and Olli CD) and centrifugal analyzers (Cobas Fara and IL Monarch 2000). Average analytical recovery was 101.5% for apo A-I and 99.4% for apo B. Dilution tests showed found/expected ratios of 101.2% (apo A-I) and 101.0% (apo B). Overall precision (CV) ranged from 1.4% to 3.3% for apo A-I and from 1.1% to 8.3% for apo B. Comparisons with commercially available rate nephelometry, radial immunodiffusion, and immunoturbidimetric methods gave good correlations (r greater than or equal to 0.938). Using the immunoturbidimetric method, we also established the relationships between apolipoproteins and lipids and determined the reference intervals. We conclude that the proposed method is suitable for routine use in clinical laboratories.


The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Clin. Nutr.Home page
F. Moloney, T.-P. Yeow, A. Mullen, J. J Nolan, and H. M Roche
Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus
Am. J. Clinical Nutrition, October 1, 2004; 80(4): 887 - 895.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
P. J. Manning, A. Allum, S. Jones, W. H. F. Sutherland, and S. M. Williams
The Effect of Hormone Replacement Therapy on Cardiovascular Risk Factors in Type 2 Diabetes: A Randomized Controlled Trial
Arch Intern Med, July 23, 2001; 161(14): 1772 - 1776.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. J. Lewis-Barned, W. H. F. Sutherland, R. J. Walker, H. L. Walker, S. A. de Jong, E. A. Edwards, and V. H. Markham
Plasma Cholesterol Esterification And Transfer, the Menopause, And Hormone Replacement Therapy in Women
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3534 - 3538.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
W. H. F. Sutherland, R. J. Walker, S. A. de Jong, A. M. van Rij, V. Phillips, and H. L. Walker
Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat
Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1340 - 1347.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. J. A. Williams, W. H. F. Sutherland, M. P. McCormick, S. A. de Jong, R. J. Walker, and G. T. Wilkins
Impaired endothelial function following a meal rich in used cooking fat
J. Am. Coll. Cardiol., March 15, 1999; 33(4): 1050 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
W. H. F. Sutherland, N. J. Restieaux, E. R. Nye, M. J. A. Williams, S. A. de Jong, M. C. Robertson, and H. L. Walker
IDL Composition and Angiographically Determined Progression of Atherosclerotic Lesions During Simvastatin Therapy
Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 577 - 583.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Association for Clinical Chemistry.